Relative tumor burden predicts metastasis‐free survival in pediatric osteosarcoma
Authors:
- 5 December 2007
- journal article
- other
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 50 (2) , 195-200
Abstract
Background: To analyze the significance of relative tumor burden in pediatric osteosarcoma.Methods: We retrospectively reviewed 241 patients with localized pediatric osteosarcoma and measured tumor size on MR images at presentation. Absolute tumor size parameters measured on MR images were converted to relative values by dividing body surface area. Both absolute and relative size parameters were analyzed for their correlation with metastasis‐free survival (MFS).Results: The 5‐year MFS was 67.5 ± 3.1%, with median follow‐up of 72 months (range, 8–205 months). In addition to poor histologic response (RR 3.24; 95% CI: 1.99–5.28; P < 0.001), large relative tumor plane (RTP; RR 3.28; 95% CI: 1.72–6.25; P < 0.001), large relative tumor area (RTA; RR 4.14; 95% CI: 1.53–11.22; P = 0.005), and large absolute tumor width (ATW; RR; 3.10; 95% CI: 1.23–7.79; P = 0.02) shortened the MFS. When survival was analyzed by combining RTP and histologic response, patients with small RTP and a good response showed the best survival (5‐year MFS of 90.2 ± 3.6%), while those with large RTP and a poor response showed the worst survival (5‐year MFS of 45.1 ± 6.6%).Conclusion: Relative two‐dimensional tumor size parameters (RTP and RTA) rather than absolute values are useful prognostic factors in pediatric osteosarcoma patients.Keywords
This publication has 36 references indexed in Scilit:
- Modeling Growth Kinetics and Statistical Distribution of OligometastasesSeminars in Radiation Oncology, 2006
- Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, ItalyEuropean Journal of Cancer, 2005
- Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trialsPediatric Blood & Cancer, 2005
- Elevated Physiologic Tumor Pressure Promotes Proliferation and Chemosensitivity in Human OsteosarcomaClinical Cancer Research, 2005
- Clinical features in osteosarcoma and prognostic implicationsJornal de Pediatria, 2004
- Neoadjuvant Chemotherapy for Osteosarcoma of the ExtremityJournal of Pediatric Hematology/Oncology, 2003
- Influence of high‐dose methotrexate therapy (HD‐MTX) on glomerular and tubular kidney functionMedical and Pediatric Oncology, 2003
- Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi‐institutional collaborative studyMedical and Pediatric Oncology, 2002
- Neoadjuvante Chemotherapie des OsteosarkomsKlinische Padiatrie, 1991
- Pharmacokinetics of Daunorubicin and Doxorubicin in Plasma and Leukemic Cells from Patients with Acute Nonlymphoblastic LeukemiaTherapeutic Drug Monitoring, 1989